162 related articles for article (PubMed ID: 35845577)
1. Mechanical Study of Jian-Gan-Xiao-Zhi Decoction on Nonalcoholic Fatty Liver Disease Based on Integrated Network Pharmacology and Untargeted Metabolomics.
Cao YJ; Li HZ; Zhao J; Sun YM; Jin XW; Lv SQ; Luo JY; Fang XX; Wen WB; Liao JB
Evid Based Complement Alternat Med; 2022; 2022():2264394. PubMed ID: 35845577
[TBL] [Abstract][Full Text] [Related]
2. Jian-Gan-Xiao-Zhi Decoction Alleviates Inflammatory Response in Nonalcoholic Fatty Liver Disease Model Rats through Modulating Gut Microbiota.
Liao J; Xie X; Gao J; Zhang Z; Qu F; Cui H; Cao Y; Han X; Zhao J; Wen W; Wang H
Evid Based Complement Alternat Med; 2021; 2021():5522755. PubMed ID: 33824675
[TBL] [Abstract][Full Text] [Related]
3. Untargeted Metabolomic Analysis of the Effects and Mechanism of Nuciferine Treatment on Rats With Nonalcoholic Fatty Liver Disease.
Cui H; Li Y; Cao M; Liao J; Liu X; Miao J; Fu H; Song R; Wen W; Zhang Z; Wang H
Front Pharmacol; 2020; 11():858. PubMed ID: 32581811
[TBL] [Abstract][Full Text] [Related]
4. Network pharmacology analysis on mechanism of Jian Pi Qing Gan Yin decoction ameliorating high fat diet-induced non-alcoholic fatty liver disease and validated in vivo.
Liu W; Shang J; Deng Y; Han X; Chen Y; Wang S; Yang R; Dong F; Shang H
J Ethnopharmacol; 2022 Sep; 295():115382. PubMed ID: 35577161
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
[TBL] [Abstract][Full Text] [Related]
6. Integrating metabolomics and network pharmacology to reveal the mechanisms of Delphinium brunonianum extract against nonalcoholic steatohepatitis.
Zhang K; Yuan Y; Dawa Z; Liu F; Yao Y; Wang M; Zhu C; Lin C
J Ethnopharmacol; 2022 Jul; 293():115268. PubMed ID: 35398502
[TBL] [Abstract][Full Text] [Related]
7. Da-Chai-Hu Decoction Ameliorates High Fat Diet-Induced Nonalcoholic Fatty Liver Disease Through Remodeling the Gut Microbiota and Modulating the Serum Metabolism.
Cui H; Li Y; Wang Y; Jin L; Yang L; Wang L; Liao J; Wang H; Peng Y; Zhang Z; Wang H; Liu X
Front Pharmacol; 2020; 11():584090. PubMed ID: 33328987
[TBL] [Abstract][Full Text] [Related]
8. Major royal jelly proteins alleviate non-alcoholic fatty liver disease in mice model by regulating disordered metabolic pathways.
Zhu YY; Meng XC; Zhou YJ; Zhu JX; Chang YN
J Food Biochem; 2022 Sep; 46(9):e14214. PubMed ID: 35510379
[TBL] [Abstract][Full Text] [Related]
9. Er-Chen Decoction Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Rats through Remodeling Gut Microbiota and Regulating the Serum Metabolism.
Miao J; Guo L; Cui H; Wang L; Zhu B; Lei J; Li P; Jia J; Zhang Z
Evid Based Complement Alternat Med; 2022; 2022():6221340. PubMed ID: 35399623
[TBL] [Abstract][Full Text] [Related]
10. Lanzhang Granules Ameliorate Nonalcoholic Fatty Liver Disease by Regulating the PPAR
Huang P; Yang L; Liu Y; Jiang Y; Li Y; Chen Z; Song H; Zheng P
Evid Based Complement Alternat Med; 2022; 2022():1124901. PubMed ID: 35035496
[TBL] [Abstract][Full Text] [Related]
11. Identify Molecular Mechanisms of Jiangzhi Decoction on Nonalcoholic Fatty Liver Disease by Network Pharmacology Analysis and Experimental Validation.
Wang L; Zhi Y; Ye Y; Zhang M; Ma X; Tie H; Ma X; Zheng N; Xia W; Song Y
Biomed Res Int; 2020; 2020():8829346. PubMed ID: 33415161
[TBL] [Abstract][Full Text] [Related]
12. Network pharmacology analysis to explore mechanism of Three Flower Tea against nonalcoholic fatty liver disease with experimental support using high-fat diet-induced rats.
Wu P; Liang S; He Y; Lv R; Yang B; Wang M; Wang C; Li Y; Song X; Sun W
Chin Herb Med; 2022 Apr; 14(2):273-282. PubMed ID: 36117665
[TBL] [Abstract][Full Text] [Related]
13. Network pharmacology-based investigation to explore the effect and mechanism of Erchen decoction against the nonalcoholic fatty liver disease.
Liu H; Xu J; Li H; Zhang L; Xu P
Anat Rec (Hoboken); 2021 Nov; 304(11):2605-2619. PubMed ID: 34536264
[TBL] [Abstract][Full Text] [Related]
14. The traditional Chinese formulae Ling-gui-zhu-gan decoction alleviated non-alcoholic fatty liver disease via inhibiting PPP1R3C mediated molecules.
Dang Y; Hao S; Zhou W; Zhang L; Ji G
BMC Complement Altern Med; 2019 Jan; 19(1):8. PubMed ID: 30616587
[TBL] [Abstract][Full Text] [Related]
15. Effects of Ganjianglingzhu Decoction on Lean Non-Alcoholic Fatty Liver Disease in Mice Based on Untargeted Metabolomics.
Tang N; Ji L; Shi X; Xiong Y; Xiong X; Zhao H; Song H; Wang J; Zhang L; You S; Ji G; Liu B; Wu N
Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675462
[TBL] [Abstract][Full Text] [Related]
16. Untargeted Metabolomics Reveals Intervention Effects of Total Turmeric Extract in a Rat Model of Nonalcoholic Fatty Liver Disease.
Wang Y; Niu M; Jia GL; Li RS; Zhang YM; Zhang CE; Meng YK; Cui HR; Ma ZJ; Li DH; Wang JB; Xiao XH
Evid Based Complement Alternat Med; 2016; 2016():8495953. PubMed ID: 27366193
[TBL] [Abstract][Full Text] [Related]
17. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
Zhang J; Du H; Shen M; Zhao Z; Ye X
J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
[TBL] [Abstract][Full Text] [Related]
18. Eight Zhes Decoction ameliorates the lipid dysfunction of nonalcoholic fatty liver disease using integrated lipidomics, network pharmacology and pharmacokinetics.
Zhou Y; Dai Z; Deng K; Wang Y; Ying J; Chu D; Zhou J; Tang C
J Pharm Anal; 2023 Sep; 13(9):1058-1069. PubMed ID: 37842659
[TBL] [Abstract][Full Text] [Related]
19. Exploring the mechanism of PingTang No.5 capsule on nonalcoholic fatty liver disease through network pharmacology and experimental validation.
Hung TC; Zhao N; Huang C; Liu S; Liu T; Huang W; Xu X; Ji ZL; Yang S
Biomed Pharmacother; 2021 Jun; 138():111408. PubMed ID: 33684693
[TBL] [Abstract][Full Text] [Related]
20. Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway.
Chen M; Xing J; Pan D; Peng X; Gao P
Biomed Pharmacother; 2020 Aug; 128():110286. PubMed ID: 32521450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
